Breast and Cervical Cancer Stigma in Rwanda

This study aims to assess breast and cervical cancer stigma and pilot a multi-modal intervention to mitigate stigma among patients, caregivers, and community health workers in Rwanda. The elements include resilience training (patient), support group (caregivers), or exposure to survivors by video and in-person (patient, caregivers, and community health workers), and educational curriculum (community health workers).

NCT Number	NCT07663006
Lead Sponsor	Dana-Farber Cancer Institute Collaborators: Dana-Farber/Harvard Cancer Center (DF/HCC) Boston, MA, American Association for Cancer Research, Breast Cancer Research Foundation
Conditions	Breast Cancer, Cervical Cancer
Enrollment	1,116 participants
Start Date	2026-11-01
Primary Completion	2027-12-01 (estimated)
Study Completion	2029-12-01 (estimated)
Updated on ClinicalTrials.gov	2026-06-23